Dr Malalur on Addressing Unmet Needs in Pancreatic Cancer
May 8th 2023Pannaga G. Malalur, MBBS, discusses several unmet needs within pancreatic cancer, including the implementation of updated germline genetic testing guidelines, increased screening of high-risk patients, and improved sequencing of available therapeutics.
Read More
Dr Malalur on the Implications of NALIRIFOX in Pancreatic Ductal Adenocarcinoma
March 29th 2023Pannaga G. Malalur, MBBS, discusses the implications of the findings for the use of liposomal irinotecan plus 5-fluorouracil, leucovorin, and oxaliplatin in the frontline setting for patients with metastatic pancreatic ductal adenocarcinoma.
Read More